Hormones Clinical Trial
Official title:
Estrogen Receptor Gene Mutations
We propose to analyze a DNA sample for mutations in the estrogen receptor gene from a patient who appears insensitive to estrogen hormone treatment.
We propose to analyze a DNA sample for mutations in the estrogen receptor gene from a patient who appears insensitive to estrogen hormone treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05022992 -
Effects of a Single Bout of Resistance Training Session on Hormonal Response in Pre-pubertal and Pubertal Boys
|
N/A | |
Terminated |
NCT04371978 -
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19
|
Phase 3 | |
Completed |
NCT04862208 -
Breakfast Consumption and Energy Balance in Active Adult Males
|
N/A | |
Recruiting |
NCT01121783 -
The Effect of Lactisole on the Responses to Glucose Solution
|
N/A | |
Completed |
NCT03677336 -
Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI
|
Phase 4 | |
Completed |
NCT04414488 -
The Impact of Regional Anaesthesia on Hormone Levels in Thoracic Surgery.
|
||
Completed |
NCT04930224 -
Serum GPER-1 and Oxidant/Antioxidant Levels on Retinopathy in Diabetic Patients
|
||
Completed |
NCT02858336 -
CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study)
|
N/A | |
Completed |
NCT05136742 -
Aerobic Exercise With Diet Induces Hormonal, Metabolic, and Psychological Changes
|
N/A | |
Recruiting |
NCT04326374 -
Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency
|
Phase 3 | |
Completed |
NCT02781727 -
A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
|
Phase 3 | |
Active, not recruiting |
NCT05288166 -
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
|
Phase 3 |